Shopping Cart
Remove All
Your shopping cart is currently empty
Giloralimab (ABBV-927) is a monoclonal antibody targeting CD40 with potential anticancer activity for the study of triple-negative breast cancer and non-small cell lung cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | - | In Stock | |
| 5 mg | $795 | - | In Stock | |
| 10 mg | $1,260 | - | In Stock | |
| 25 mg | $1,870 | - | In Stock | |
| 50 mg | $2,520 | - | In Stock |
| Description | Giloralimab (ABBV-927) is a monoclonal antibody targeting CD40 with potential anticancer activity for the study of triple-negative breast cancer and non-small cell lung cancer. |
| Synonyms | ABBV-927, ABBV927 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF5/CD40 |
| Molecular Weight | 146.34 kDa |
| Cas No. | 2226292-20-0 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.